Integrated and modularized drug concentration gradient generation and administration device
Through integrated and modular drug concentration gradient generation and drug delivery device, the brake module is used to drive the drug concentration gradient plate downward, and combined with specific retention sites, the problem of fine regulation and individualized treatment in traditional drug delivery methods is solved. , realizes efficient and accurate drug administration, suitable for drug screening and clinical treatment.
Patent Information
- Application Number
- CN202411031223.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-30
- Publication Date
- 2024-11-15
AI Technical Summary
Traditional administration methods cannot provide finely regulated drug release curves, difficult to meet the needs of individualized treatments, and there is variability in the manual preparation concentration gradient, affecting the efficiency and credibility of drug development and clinical treatment.
An integrated and modular drug concentration gradient generation and drug delivery device was designed. The drug concentration gradient plate was driven down through the brake module, so that the specific residency site was combined with the drug to form a stable drug concentration gradient, which was suitable for A variety of experimental and treatment scenarios. The device includes a culture module, a drug concentration gradient generation plate, a positioning column and a probe column. The probe column is equipped with a resident site, and the formation of a drug concentration gradient is achieved by controlling the area and chemical or biological properties of the resident site.
It realizes the accuracy and flexibility of drug screening and clinical administration, reduces the cumbersomeness of traditional manual operations, improves the throughput and repeatability of tests, adapts to personalized medical needs, reduces drug side effects, and improves therapeutic results. and patient quality of life.
Smart Images

Figure CN118956573A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field related to drug delivery devices, and more specifically, relates to an integrated and modular drug concentration gradient generation and delivery device. Background Art
[0002] In the field of drug research and clinical treatment, the advancement of drug delivery technology directly affects the optimization of drug efficacy and the improvement of drug safety. Precise drug delivery technology can ensure that the drug reaches the ideal concentration in the body to achieve the best therapeutic effect and minimize side effects. However, traditional drug delivery methods usually have some limitations, such as the inability to provide a finely regulated drug release curve, which makes it difficult to meet the needs of individualized treatment.
[0003] In the early stages of drug development, high-throughput drug screening is a key step in screening effective drug candidate molecules. This process requires evaluating drugs at a range of different concentrations to determine their activity, selectivity, toxicity, and therapeutic window. However, traditional drug screening often relies on manual preparation of concentration gradients, which is not only time-consuming and labor-intensive, but also prone to variability due to improper human operation. This variability may lead to inaccurate and inconsistent data, thus affecting the efficiency and credibility of the entire drug development process.
[0004] In addition, in clinical treatment, due to the physiological differences between individuals and the differences in the stages of disease development, it is necessary to adjust the drug dosage individually to suit the specific conditions of different patients. The current drug delivery system is often unable to flexibly adapt to these changes, resulting in the inability to provide the most optimized treatment plan for each patient.
[0005] There is an urgent need for a drug delivery method that can provide precise drug concentration control. This advanced drug delivery method can not only improve the efficiency of drug screening and drug development, but also realize personalized medicine, optimize drug treatment plans according to the specific needs of patients, and ultimately improve treatment outcomes, reduce unnecessary drug side effects, and improve the quality of life of patients. Summary of the invention
[0006] In response to the above defects or improvement needs of the prior art, the present invention provides an integrated and modular drug concentration gradient generating and drug delivery device, the purpose of which is to drive the drug concentration gradient plate to move downward through a braking module, so that the specific retention site on the probe column arranged between the positioning site and the isolation chamber combines with the drug to form a stable drug concentration gradient for precise drug delivery, which is suitable for a variety of experimental and treatment scenarios, thereby solving technical problems such as manual preparation of concentration gradients and variability caused by improper human operation.
[0007] To achieve the above object, according to one aspect of the present invention, an integrated and modular drug concentration gradient generation and drug administration device is provided, comprising a culture module and a drug concentration gradient generation plate arranged from bottom to top;
[0008] The culture module comprises an array of isolated chambers, a plurality of positioning posts arranged at the edge of the culture module and connected to the drug concentration gradient generating plate, and a brake module arranged on the positioning posts to drive the drug concentration gradient generating plate to move downward toward the culture module;
[0009] The drug concentration gradient generating plate comprises a supporting base plate, a positioning site arranged on one side of the supporting base plate, and a probe column fixed between the supporting base plate and the isolation chamber through the positioning site; the probe column and the isolation chamber correspond one to one; a retention site is arranged on the probe column, and the area of the retention site is linearly changed in each column and / or each row of the isolation chamber.
[0010] As a preferred embodiment of the present invention, the retention site is arranged on the surface of the probe column facing the isolation chamber.
[0011] As a preferred embodiment of the present invention, the retention site is a drug retention structure attached to the probe column in a direction facing the isolation chamber, including a coating structure or a stamp pattern modification;
[0012] Or the retention site is a drug retention structure formed by modifying the surface of the probe column facing the isolation chamber, including a multi-groove structure or a multi-layer film structure in a groove.
[0013] As a preference of the present invention, the length of the combined structure formed by each group of probes equipped with retention sites is the same, different, or linearly varied in each column and / or row of the isolation chamber.
[0014] As a preferred embodiment of the present invention, the probe column and the residence site are integrated or detachable.
[0015] As a preferred embodiment of the present invention, the outer wall of the probe column is hydrophilically modified.
[0016] As a preferred embodiment of the present invention, the array channel area further comprises an open flow channel composed of a plurality of flow channels arranged side by side, and the open flow channel is bonded above the isolation chamber arranged in the array.
[0017] As a preferred embodiment of the present invention, the brake module includes a linear brake or a spring column.
[0018] As a preferred embodiment of the present invention, a controller is connected to the braking module.
[0019] As a preferred embodiment of the present invention, a display monitoring module is connected to the controller.
[0020] In general, the above technical solutions conceived by the present invention have the following beneficial effects compared with the prior art:
[0021] (1) The drug concentration gradient generation and drug delivery device of the present invention drives the drug concentration gradient generation plate to move downward through the braking module, and adjusts the area of the specific drug retention site on the drug probe column or controls the drug delivery mechanism, so that the specific retention site on the probe column set between the positioning site and the isolation chamber combines with the drug to form a stable drug concentration gradient, thereby performing precise drug delivery, which provides great flexibility and accuracy for drug screening and clinical drug delivery.
[0022] (2) The side wall of each probe column on the drug concentration gradient generation and drug delivery device of the present invention is hydrophilically modified to capture liquid, allowing the liquid to climb to the surface of the probe column without overflowing; each probe column is provided with a specific drug retention site of controllable area on the surface facing the isolation chamber, which is convenient for batch formation and fixation of different drug concentration gradients.
[0023] (3) The retention site in the drug concentration gradient generating and drug delivery device of the present invention is used to retain liquid, and its area gradient determines the gradient of drug concentration. When the drug is applied in the form of droplets, the drug loading height will change with the effective radius of the retention site due to the different areas of the retention site, that is, the volume size of the hemisphere changes, thereby forming an exponential gradient.
[0024] The drug retention site has a variety of chemical or biological properties and may or may not be a specific structure. It is arranged on the side of the drug probe column facing the isolation chamber through a coating structure, a stamp pattern modification (the modified retention site has no physical structural changes), a physical groove structure, a multi-groove structure or a multi-layer film structure in a groove (the physical volume change is a specific structure). The principle of achieving different drug concentration gradients is to capture different amounts of liquid for different drugs according to the area or volume of the retention site, and then freeze-dry and re-thaw into the isolation chamber of the culture module with the same liquid to achieve the formation of a concentration gradient.
[0025] (4) The length of the combined structure of the probe column and the matching retention site in the drug concentration gradient generation and drug delivery device of the present invention can be the same, different, or linearly varied in each row or column of the isolation chamber to form a drug concentration gradient at different depths.
[0026] (5) The probe column and the retention site in the drug concentration gradient generation and drug delivery device of the present invention are designed to be integrated or modular. The integrated design facilitates rapid assembly and use; the modular design enables rapid replacement or reconfiguration of the drug retention site to meet the testing requirements of different drugs, reduces the cumbersome manual operations in traditional drug testing, and improves the throughput and repeatability of the test.
[0027] (6) The culture module in the drug concentration gradient generation and drug delivery device of the present invention is provided with a variety of structures with isolated chambers, and is provided with multiple independent channels, each channel corresponding to a row of probe columns, so as to achieve independent control of the drug concentration gradient in each row.
[0028] (7) The drug concentration gradient generation and drug delivery device of the present invention can be manually operated or integrated with an automated device. The controller connects the brake module and the culture module in succession to achieve orderly drug release.
[0029] (8) The drug concentration gradient generation and drug delivery device of the present invention has the potential to be combined with automated equipment. Its design can be used in conjunction with imaging equipment for imaging monitoring to make a visual assessment of the drug delivery effect. This can not only track the drug delivery effect in real time, but also make immediate adjustments when necessary, thereby improving the responsiveness of the treatment.
[0030] In summary, each probe column in the drug delivery device of the present invention is equipped with a specially designed retention site, which realizes the stable loading and gradual release of the drug through the physicochemical recognition mechanism. The precise gradient distribution of the drug in the culture medium in the isolation chamber of the culture module is achieved through the braking module, providing an ideal biological model system for drug sensitivity testing of three-dimensional cell spheroids or organoids. In addition, this drug delivery method can not only rely on manual operation to meet the research needs of simple or specific conditions, but can also be easily integrated into an automated system, providing high flexibility and convenience for drug screening, pharmacodynamic evaluation, toxicology research and clinical treatment. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1 It is a schematic diagram of the structure of a drug concentration gradient generating and drug delivery device according to an example of the present invention;
[0032] Figure 2 Schematic diagram of the formation of non-specific drug retention sites according to the present invention; wherein, Figure 2 A represents different modification methods, and B represents the method of preventing liquid from overflowing.
[0033] Throughout the drawings, the same reference numerals are used to denote the same elements or structures, wherein:
[0034] 1-support base plate, 2-positioning site, 3-probe column, 4-retention site, 5-positioning column, 6-culture module, 7-isolation chamber. DETAILED DESCRIPTION
[0035] In order to make the purpose, technical solutions and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention. In addition, the technical features involved in the various embodiments of the present invention described below can be combined with each other as long as they do not conflict with each other.
[0036] like Figure 1 As shown, the present invention provides an integrated and modular drug concentration gradient generation and drug administration device, which includes a culture module 6 and a drug concentration gradient generation plate arranged from bottom to top.
[0037] The culture module 6 includes a plurality of isolation chambers 7 , positioning posts 5 corresponding to the isolation chambers, and a braking module disposed on the positioning posts 5 .
[0038] Several isolation chambers 7 are arranged in an array and can be operated independently; several positioning columns 5 are evenly arranged on the edge of the culture module 6 and connected to the drug concentration gradient generating plate, which are used to support the drug concentration gradient generating plate above the culture module 6; a braking module is also provided on the positioning column 5, which is used to drive the drug concentration gradient generating plate to move downward in the direction of the culture module 6.
[0039] Specifically, the positioning columns 5 are specifically connected between the culture module 6 and the support plate of the drug concentration gradient generating plate, and the number of the positioning columns 5 is selected according to the design requirements, so that the support for the drug concentration gradient generating plate to be evenly stressed is set above the culture module 6.
[0040] Among them, the drug concentration gradient generating plate includes a supporting base plate 1, a positioning site 2 arranged on one side of the supporting base plate 1, an array-arranged probe column 3 and a retention site 4 arranged on the probe column 3, and the probe column 3 and the isolation chamber 7 correspond one to one to ensure that the drug probe column can probe into the isolation chamber 7.
[0041] The probe column 3 is fixed by the positioning site 2 and limited between the supporting base plate 1 and the isolation chamber 7; the resident site 4 is linearly variedly arranged on each column and / or each row of the isolation chamber 7.
[0042] Each of the above-mentioned probe columns has a hydrophilic modification on its sidewalls to capture liquids, and a controllable area of specific drug retention sites is provided on the side facing the isolation chamber, which facilitates batch formation and fixation of different drug concentration gradients. The above-mentioned retention sites are retention sites for specific drugs, and the specificity of the drug retention sites is based on physicochemical affinity or biorecognition elements to achieve selective binding to specific drug molecules.
[0043] Preferably, the retention sites 4 have a variety of different chemical or biological properties so as to specifically bind to a variety of drugs and form multiple drug concentration gradients.
[0044] The residence site 4 can be a patterned modification attached to the surface of the probe column 3 facing the isolation chamber 7, or a specific physical structure. Specifically:
[0045] The retention site 4 is a drug retention structure attached to the probe column 3 in the direction facing the isolation chamber 7, including a coating structure or a stamp pattern modification;
[0046] Or the retention site 4 is a drug retention structure formed by modifying the surface of the probe column 3 facing the isolation chamber 7, including a physical groove structure, a multi-groove structure or a multi-layer film structure in a groove.
[0047] Preferably, the positioning site is a concentric circle structure arranged on one side of the supporting base plate 1 .
[0048] Preferably, the length of each combination of the probe column 3 and the retention site 4 is the same, different, or linearly varied in each column and / or row of the isolation chamber 7 .
[0049] Different combinations of the lengths of the probe column 3 and the retention site 4 are used to form drug concentration gradients at different depths.
[0050] Preferably, the probe column 3 and the retention site 4 are integrated or detachable. The integrated design facilitates quick assembly and use, and the modular design facilitates personalized customization and replacement. For example, the detachable modular probe column 3 is used to replace or reconfigure the drug retention site according to the physicochemical properties of the drug and the treatment requirements.
[0051] Preferably, the outer wall of the probe column 3 is hydrophilically modified so that the probe can grab the liquid and prevent the liquid from overflowing.
[0052] Preferably, a plurality of independent channels are provided in the support base plate 1, and each channel corresponds to a row of probe columns 3, so as to realize independent control of the drug concentration gradient in each row.
[0053] For example, the array channel area also includes an open channel composed of multiple channels arranged side by side, and the open channel is bonded above the isolation chamber 7 arranged in the array, and each channel corresponds to a row of probe columns 3 to achieve independent control of the drug concentration gradient in each row.
[0054] The isolation chamber 7 is a concave structure, which is prepared by bonding an array pattern underneath holes arranged in an array.
[0055] Preferably, the specific structure of the culture module of the present invention refers to the design of a culture chip based on open chamber patterned array microfluidics in Application No.: 2024106466668, including: an open chamber cover plate and an array channel layer stacked sequentially from top to bottom;
[0056] The array channel layer includes: an open channel area composed of multiple flow channels arranged side by side and a culture fluid storage chamber connected to the outlet of the open channel area, and a hole array layer and a patterned array bonded in sequence below the open channel area; the hole rows in the hole array layer and the pattern rows in the patterned array correspond directly below the flow channels, and the holes in the hole array layer and the patterns of the patterned array correspond to each other one by one to form an isolated chamber array; the open chamber cover has a hollow opening in the middle, and the two ends of the open chamber cover have an inlet connected to the open channel area, and a sample outlet connected to the culture fluid storage chamber; the hollow opening is the same size as the open channel area.
[0057] Based on the above-mentioned integrated and modular drug concentration gradient generation and drug delivery device, a drug concentration gradient generation and drug delivery method is provided, which uses a three-dimensional cell spheroid or organoid culture module and a drug concentration gradient generation plate to generate a drug concentration gradient and deliver the drug. The three-dimensional cell spheroid or organoid culture module has several isolation chambers and positioning columns for positioning the drug generation plate; the supporting bottom plate of the drug concentration gradient generation plate provides a solid foundation for the entire device, and the positioning site ensures that the drug probe column is accurately installed; the probe column array is arranged, and each probe column is equipped with a specific drug retention site, whose area can be adjusted to form different drug concentration gradients; specific drug retention sites, these sites can specifically bind to specific drug molecules, based on physicochemical affinity or biorecognition elements; by controlling the area of the retention site, a precise drug concentration gradient is formed; the method can be integrated with a manual or automated drug delivery mechanism to provide a flexible drug delivery method.
[0058] The specific steps include:
[0059] (1) Drug loading: Prepare a drug solution of a predetermined concentration, apply or dip the drug solution to the retention site on the drug probe column, and use the specificity of the retention site to retain the drug, thereby forming a drug concentration gradient.
[0060] A stable drug concentration gradient is generated and maintained by controlling the area of drug penetration into the drug retention sites on the column and / or by controlling the drug delivery mechanism.
[0061] This involves adjusting the chemical or biological properties of the drug retention site to optimize the binding efficiency and stability with the drug molecule.
[0062] It is also possible to detect responses to specific biomarkers by adjusting the specificity of the drug's residence site.
[0063] (2) Drug fixation: After the drug is retained, freeze-drying or air-drying is used to fix the drug on the probe column.
[0064] The gradient-sized drug retention sites formed by the device, when applied in the form of droplets, have longitudinal changes not only in size but also in depth, that is, the size of the hemisphere changes, thereby forming an exponential gradient.
[0065] (3) Drug administration: The drug concentration gradient generating plate and the positioning column on the culture module are manually pressed or the drug column is inserted into the culture module using an automated device. Stable drug loading and gradual release are achieved by manual pressing or automated integration.
[0066] The invention provides a method for generating a drug concentration gradient and administering the drug based on a specific drug retention site. The drug concentration gradient generating plate in the method forms a stable drug concentration gradient through the combination of the specific retention site and the drug, and can perform precise administration.
[0067] A detailed fabrication of an integrated and modular drug concentration gradient generation plate and drug delivery device is presented.
[0068] A production process of a fixed drug concentration gradient generating plate:
[0069] (1) First, prepare a 1mm thick polymethyl methacrylate sheet and directly use a laser engraving machine to engrave it. Figure 1 The structure of the supporting base plate shown;
[0070] (2) Prepare another piece of polymethyl methacrylate sheet with the required length of the probe column. After peeling off the film on one side, stick a special double-sided tape on it and use a laser engraving machine to engrave the following Figure 1 The cylindrical structure shown in the figure has a reduced material portion left as a positioning plate;
[0071] (3) Prepare a piece of pressure-sensitive adhesive and use a laser engraving machine to engrave directly. Figure 1 The array pattern structure shown is for standby use;
[0072] (4) Align the engraved positioning plate with the bottom plate structure, peel off the double-sided adhesive layer of the cylinder under the action of the fixing plate and put it into the positioning hole for bonding;
[0073] (5) Put the assembled whole structure, including the positioning plate, into a hot press with the upper and lower pressing surfaces at 60°C for 5 minutes;
[0074] (6) After the temperature of the hot-pressed module returns to room temperature, it is placed in pure water for 24 hours of ultrasonic treatment and then blown dry with a nitrogen gun.
[0075] Steps for generating a drug concentration gradient and forming a residence site 4 of a drug delivery device:
[0076] (1) Adhere the pressure-sensitive adhesive having an array pattern structure to the positioning pillars after peeling off the film;
[0077] (2) placing the attached device in an oxygen plasma machine for treatment to form local hydrophilic array sites on its surface;
[0078] Drug loading steps for fixed drug concentration gradient generation plate:
[0079] (1) Pre-prepared solution with fixed drug concentration
[0080] (2) tear off the pressure-sensitive adhesive on the surface of the fixed drug concentration gradient generating and drug delivery device, and use the pressure-sensitive adhesive discarding film structure to cover the surface of the positioning column as a support;
[0081] (3) Add a solution with a fixed drug concentration to the side of one row of the array and apply it using a glass slide;
[0082] (4) The drug solution forms droplets of different sizes under the action of the hydrophilic sites, and the pressure-sensitive adhesive film structure is removed;
[0083] (5) Place the drug-loaded device in a -80° refrigerator for 30 min, then transfer it to a vacuum freeze dryer and remove it after 12 h for later use.
[0084] Combining the Stamp Method to Elucidate the Formation of Drug-Specific Sites
[0085] Its structure is basically the same as above, and the preparation method and drug loading steps are not described in detail. The main difference lies in the formation of drug-specific sites, which is described in detail below.
[0086] (1) Carve an extra base structure when carving;
[0087] (2) applying glue to one side of a porous adsorbent material including but not limited to sponge, cutting out a patterned array structure, and leaving the reduced material portion for positioning;
[0088] (3) Align the engraved positioning plate with the positioning part peeling film, peel off the double-sided adhesive layer of the cylinder under the fixing effect and put it into the positioning hole for bonding to form a patterned seal;
[0089] (4) Dipping in a hydrophilic or hydrophobic reagent to generate a drug concentration gradient and perform drug-specific site modification on the drug delivery device, such as positive modification and negative modification; the modification site made by the negative modification method can use the dipping drug loading method.
[0090] The formation of non-specific drug retention sites is described; specific drug retention sites, which are selective sites formed by hydrophilic, hydrophobic, chemical or biological methods, have both advantages and disadvantages. The disadvantage is the selectivity of the treatment to the drug itself.
[0091] Here we describe two non-specific drug retention sites in detail. The preparation methods are roughly the same as those described above. The differences between the two methods are described below:
[0092] The method is the same as Figure 2 (1) and (2) of Figure A in FIG: At the beginning of the device processing, hot pressing or injection molding is used to form holes of different sizes and depths in the probe column. The holes do not need any treatment and can be directly coated and fixed with drugs. Or Figure 2 In (3) of Figure A, a soluble film is set in the hole, which can be used to embed two or more drugs that cannot react in advance.
[0093] Method 2 Figure 2 (4) of Figure A in the figure: In this device, the double-sided film is peeled off during the processing of the probe column, and the double-sided adhesive is pasted on the double-sided adhesive surface. During laser engraving, a patterned array relief is directly made on the double-sided adhesive layer to form a double-sided adhesive pattern cosmetic array. The device can directly dip the drug to form a gradient.
[0094] In addition, for shallow reaction systems, the probe column can be used as follows Figure 2 As shown in (1) of Figure B in the figure, the periphery of the probe column is hydrophilically modified so that the liquid can be captured when the probe enters the reaction system; or as shown in Figure 2 As shown in (2) of Figure B in the figure, a valve is added to the probe column to limit the volume of the probe.
[0095] Combining a detachable drug concentration gradient generating plate
[0096] Its structure is basically the same as the above, and the manufacturing method and drug loading steps are not described in detail. The detachable part is mainly described in detail.
[0097] Each probe column is an independent body with a rotating buckle on the column head; the probe columns are grouped into rows, and each row has a fixed buckle chamber, allowing each probe to be assembled separately; the bottom plate is a hollow structure with a card slot inside, allowing single row assembly.
[0098] Explain the operation methods of drug concentration gradient generation and drug administration
[0099] There are two types of usage:
[0100] Manual pressing method: Use the positioning column set on the culture module to fix the drug concentration gradient generation and the drug administration plate and the culture module, and realize the drug gradient release by manual pressing.
[0101] Automation equipment integration method:
[0102] (1) Using the positioning column set on the culture module, a spring is installed on the positioning column to pre-integrate the drug concentration gradient generation plate with the culture module, and the drug gradient release is achieved by pressing the device at a fixed time.
[0103] (2) Magnets are directly installed on the bottom plate structure of the drug concentration gradient generating plate, integrated with the automated equipment, and the device is moved downward at a fixed time to achieve drug gradient release.
[0104] A fixed drug concentration gradient generating plate for multiple drug administration and drug administration method
[0105] This embodiment further provides a method for using a fixed drug concentration gradient generating and drug delivery device for multiple drug delivery and combined drug delivery. Figure 1 As shown, this method is suitable for realizing high-throughput screening experiments of multiple drug combinations and performing complex drug exposure on cells or biological samples.
[0106] The production steps are as follows:
[0107] (1) According to the method of Example 1, a plurality of fixed drug concentration gradient generating plates are prepared to load different drugs or drug solutions of different concentrations.
[0108] (2) A set of modular drug retention sites is designed for each drug concentration gradient generation plate to facilitate experiments with different drug combinations.
[0109] (3) A dedicated drug retention site plate is configured for each drug or drug combination. The number and position of drug probes and drug retention sites on each plate correspond to the experimental design.
[0110] (4) Using the drug loading steps in Example 1, each retention site plate is loaded with drug and set aside.
[0111] The steps for drug administration are as follows:
[0112] (5) Determine the drug combination and sequence required for the experiment, and prepare and label the corresponding drug concentration gradient generation plate before the experiment begins.
[0113] (6) Fixing the drug concentration gradient generation plate required for the first administration on the culture module, and performing the first administration.
[0114] (7) After the first administration is completed, the drug concentration gradient generating plate is removed from the culture module and replaced with the drug concentration gradient generating plate required for the next administration.
[0115] (8) Repeating steps (6) and (7) to achieve multiple or combined administration to the same cell or biological sample.
[0116] (9) After each replacement of the drug retention site plate, check and confirm the drug loading of the new plate to ensure that it is correctly and evenly loaded on the plate.
[0117] (10) After the drug administration experiment is completed, the cells or biological samples are subjected to corresponding biomarkers and tests to analyze the effects of different drug combinations on the samples.
[0118] It will be easily understood by those skilled in the art that the above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. An integrated and modular drug concentration gradient generation and drug delivery device, characterized in that: It includes a culture module (6) and a drug concentration gradient generation plate arranged from bottom to top; The culture module (6) comprises an array-arranged isolation chamber (7), a plurality of positioning posts (5) arranged at the edge of the culture module (6) and connected to the drug concentration gradient generating plate, and a braking module arranged on the positioning posts (5) for driving the drug concentration gradient generating plate to move downward toward the culture module; The drug concentration gradient generating plate comprises a supporting base plate (1), a positioning site (2) arranged on one side of the supporting base plate (1), and a probe column (3) fixed between the supporting base plate (1) and the isolation chamber (7) through the positioning site (2); the probe column (3) and the isolation chamber (7) correspond one to one; a retention site (4) is arranged on the probe column (3), and the area of the retention site (4) is linearly changed in each column and / or each row of the isolation chamber (7).
2. The integrated and modular drug concentration gradient generation and drug delivery device according to claim 1, characterized in that: The retention site (4) is arranged on the surface of the probe column (3) facing the isolation chamber (7).
3. The integrated and modular drug concentration gradient generation and drug delivery device according to claim 2, characterized in that: The retention site (4) is a drug retention structure attached to the probe column (3) in a direction facing the isolation chamber (7), including a coating structure or a stamp pattern modification; Or the retention site (4) is a drug retention structure formed by modifying the surface of the probe column (3) facing the isolation chamber (7), including a multi-groove structure or a multi-layer film structure in a groove.
4. The integrated and modular drug concentration gradient generation and drug delivery device according to claim 2, characterized in that: The length of the combined structure formed by each group of probes (3) equipped with the residence sites (4) is the same, different, or linearly varied in each column and / or row of the isolation chamber (7).
5. The integrated and modular drug concentration gradient generation and drug delivery device according to claim 1, characterized in that: The probe column (3) and the residence site (4) are integrally arranged or detachably arranged.
6. The integrated and modular drug concentration gradient generation and drug delivery device according to claim 1, characterized in that: The outer wall of the probe column (3) is hydrophilically modified.
7. The integrated and modular drug concentration gradient generation and drug delivery device according to claim 1, characterized in that: The array channel area also includes an open flow channel composed of a plurality of flow channels arranged side by side, and the open flow channel is bonded above the isolation chamber (7) arranged in the array.
8. The integrated and modular drug concentration gradient generation and drug delivery device according to claim 1, characterized in that: The brake module comprises a linear brake or a spring column.
9. The integrated and modular drug concentration gradient generation and drug delivery device according to claim 1, characterized in that: Also includes: A controller is connected to the brake module.
10. The integrated and modular drug concentration gradient generation and drug delivery device according to claim 8, characterized in that: Also includes: The display monitoring module is connected with the controller.
Citation Information
Cited By
Rectal tumor organ-like chip drug sensitivity detection kit and use method thereof
CN119410587A
A rectal tumor organoid chip drug sensitivity detection kit and its use method
CN119410587B
